These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 5431239

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Therapeutic agents for lipid metabolism disorders--with special reference to arterial diseases].
    Murakami M, Sekimoto H, Nagai T, Nakata I, Takekoshi T.
    Nihon Rinsho; 1970 Mar 25; 28 Suppl():696-9. PubMed ID: 5430846
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical evaluation of the therapeutic activity of the -pyridyl-carbinol ester of clofibric acid].
    Silingardi V, Renzi R, Mora A, Di Prisco AU.
    Minerva Med; 1973 Mar 21; 64(16):751-69. PubMed ID: 4704721
    [No Abstract] [Full Text] [Related]

  • 6. [Abnormal lipid metabolism and coronary insufficiency].
    Murakami M, Sekimoto H, Tanaka I, Seo M, Takegoshi T.
    Saishin Igaku; 1970 Jan 10; 25(1):101-9. PubMed ID: 5450347
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM, Attia O, Nabih AE, Nassar I, Ibrahim WN.
    J Trop Med Hyg; 1970 Jul 10; 73(7):177-81. PubMed ID: 5470220
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of clofibrate on serum lipid pattern in patients with arteriosclerosis].
    Markiewicz K, Walasek L, Pelka W, Lutz W.
    Pol Tyg Lek; 1973 Jul 23; 28(30):1144-7. PubMed ID: 4732710
    [No Abstract] [Full Text] [Related]

  • 17. [Further data on the use of a preparation with antisclerotic action in geriatrics].
    Solaro F, Zinnari A, Dinale M.
    G Gerontol; 1970 Mar 23; 18(3):177-84. PubMed ID: 5473220
    [No Abstract] [Full Text] [Related]

  • 18. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    J Pharm Sci; 1975 Jan 23; 64(1):261-9. PubMed ID: 1094102
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The effect of retabolyl on the lipid and protein metabolism of coronary atherosclerosis patients].
    Savenkov PM, Segal' RG.
    Kardiologiia; 1969 Jul 23; 9(7):95-100. PubMed ID: 5372695
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.